Neuroantigen-specific CD8+ T cells were abundant in the CNS of MS patients and a higher prevalence of CD8+ T cell responses was noted in patients with relapsing-remitting MS (Babbe et al, 2000; Crawford et al, 2004). This evidence concerns the gene CD8A and myeloid sarcoma.